Bell Bank Has $3.71 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bell Bank lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,324 shares of the healthcare conglomerate’s stock after purchasing an additional 142 shares during the quarter. Bell Bank’s holdings in UnitedHealth Group were worth $3,705,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. State Street Corp lifted its stake in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares during the last quarter. Geode Capital Management LLC boosted its position in UnitedHealth Group by 1.6% during the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after purchasing an additional 318,039 shares during the period. Franklin Resources Inc. raised its position in shares of UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after purchasing an additional 193,800 shares during the period. Fisher Asset Management LLC boosted its holdings in UnitedHealth Group by 3.5% during the third quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock valued at $1,869,320,000 after acquiring an additional 107,097 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. increased its position in UnitedHealth Group by 0.5% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,619,549 shares of the healthcare conglomerate’s stock worth $1,325,125,000 after buying an additional 12,322 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $465.58 on Friday. The company has a market cap of $428.46 billion, a PE ratio of 30.04, a PEG ratio of 1.37 and a beta of 0.61. The firm’s 50-day moving average price is $519.27 and its 200-day moving average price is $560.54. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the company posted $5.83 EPS. The firm’s revenue was up 6.8% on a year-over-year basis. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on UNH shares. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. KeyCorp reiterated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.